A quarter of the S&P 500 companies report earnings next week, and that could buffet the market as investors await the July Fed meeting.Market Insiderread more
Iran's Revolutionary Guard claims the British tanker, Stena Impero, failed to follow international maritime rules.World Newsread more
Amazon hires Trump-allied lobbyist Jeff Miller as battle for Pentagon contract heats up.Politicsread more
In a series of tweets, the president addressed an unusual controversy stemming from a speech delivered Thursday by New York Fed President John Williams.Marketsread more
"You need to understand that we're about to embark on the busiest week of the year for industrial earnings," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Boston Federal Reserve President Eric Rosengren is lining up against an apparent push to cut interest rates, telling CNBC in an interview Friday that the central bank can...The Fedread more
The MTA reported that the 1, 2, 3, 4, 5 and 6 trains are all facing delays due to a network communications issue impacting service in both directions, NBC New York reports.Transportationread more
Companies aren't waiting for the U.S.-China trade war to be resolved, says the head of the world's biggest money manager.Investingread more
US officials including Treasury Secretary Steven Mnuchin and White House economic adviser Larry Kudlow will host a meeting at the White House on Monday of semiconductor and...Technologyread more
Trump's constant berating of the Fed and its actions does not influence the central bank's decisions, Boston Fed's Eric Rosengren says.The Fedread more
The lawsuits allege J&J's talc-based baby powder contained asbestos and caused ovarian and other cancers.Health and Scienceread more
The $69 billion deal is currently making its way through the regulatory process.
CVS announced in December it was buying the health insurer, and in March shareholders from both companies approved the merger. The companies are now waiting for the Department of Justice to approve the deal.
The recent ruling by a federal judge allowing the merger between A&T and Time Warner is seen by many as a go-ahead on so-called vertical mergers. CVS Health was seen by Wall Street as a clear winner from that verdict earlier this month, with its shares jumping 3 percent on the news.
However, Merlo told CNBC he thinks that partnership will be good for CVS.
"We think that there's a lot of parallels in terms of what we're looking to do with CVS and Aetna coming together and what … they're planning to do in terms of this announcement," he said.
"We'll look forward to getting together at the appropriate time to compare notes and see how we might work together."
Earlier this week, CVS announced it will roll out delivery for prescription drugs — before Amazon, which has been eyeing the prescription drug market.
— CNBC's Angelica LaVito contributed to this report.